All In Biotech

Free tool

FAERS Monitor: Spinraza

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209531 or its brand name (Spinraza, Nusinersen Sodium). Reports on generic versions are filed under their own applications.

Reports

7,888

Serious

3,872

49% of reports

Hospitalization

2,401

Death reported

798

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • headache578
  • post lumbar puncture syndrome524
  • pyrexia410
  • procedural pain386
  • pneumonia371
  • death339
  • vomiting315
  • asthenia302
  • back pain265
  • fatigue253
  • scoliosis230
  • fall186
  • malaise184
  • nausea177
  • pain164

Reports by year received

View as table
YearReports
20161
2017637
20181,223
2019945
2020800
2021958
2022801
2023729
2024624
2025594
2026576

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,271 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
post lumbar puncture syndromeSignal5242709.52404.2702,601
scoliosisSignal230102.890.322,229
procedural painSignal38637.634.113,548
pyrexiaSignal4103.22.9613
pneumoniaSignal3713.12.8519
back painSignal2653.02.7365
headacheSignal5782.52.3514
astheniaSignal3022.11.9186
vomiting3151.81.6111
fall1861.51.330
malaise1841.11.02
death3391.00.91
fatigue2530.90.85
pain1640.70.619
nausea1770.60.550

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.